Showing results (51-60 of 130) with videos related to

Sort By:
Pageof 13
The American Journal of Pathology|January 9, 2010
Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cellsValérie Gratio, Nathalie Beaufort, Lina Seiz, et al.
Biological Chemistry|April 12, 2018
Insights into the activity control of the kallikrein-related peptidase 6: small-molecule modulators and allosterismFeryel Soualmia, Elodie Bosc, Sabrina Aït Amiri, et al.
The Journal of Biological Chemistry|November 20, 2015
A Single Glycan at the 99-Loop of Human Kallikrein-related Peptidase 2 Regulates Activation and Enzymatic ActivityShihui Guo, Wolfgang Skala, Viktor Magdolen, et al.
BMC Cancer|July 17, 2019
Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancerWeiwei Gong, Yueyang Liu, Christof Seidl, et al.
Gynecologic Oncology|September 12, 2012
Combined expression of KLK4, KLK5, KLK6, and KLK7 by ovarian cancer cells leads to decreased adhesion and paclitaxel-induced chemoresistanceDaniela Loessner, Verena M C Quent, Julia Kraemer, et al.
Biological Chemistry|August 10, 2006
Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinomaJulia Dorn, Nadia Harbeck, Ronald Kates, et al.
Journal of Proteomics|April 24, 2018
Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approachIlijana Begcevic, Davor Brinc, Marshall Brown, et al.
Translational Neurodegeneration|August 31, 2019
Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PETOliver Goldhardt, Inanna Warnhoff, Igor Yakushev, et al.
American Journal of Cancer Research|July 10, 2020
High levels of KLK7 protein expression are related to a favorable prognosis in triple-negative breast cancer patientsXiaocong Geng, Lamiya Babayeva, Axel Walch, et al.
Expert Review of Molecular Diagnostics|November 18, 2010
Clinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1Manfred Schmitt, Karin Mengele, Rudolf Napieralski, et al.
Pageof 13